Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of bencycloquidium bromide nasal spray for persistent allergic rhinitis
ChiCTR2000030924Phase 3Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in persistent allergic rhinitis (PAR) comparing Bencycloquidium Bromide Nasal Spray group with Placebo group (2 arms). Primary endpoint: Visual analog scale. Started Mar 2012; status: completed.
02
Drugs
Bencycloquidium bromide
03
Conditions
persistent allergic rhinitis (PAR)
Beyond the preview
Go deeper on ChiCTR2000030924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030924.